ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,331Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 676

$615K Total Retail Price of All Prescriptions

Rank: 170 out of 676

429 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

20% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 9,775 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 599 398 S3 1 1
AMLODIPINE BESYLATE 465 415 2 3
PRAVASTATIN SODIUM 459 375 3 11
METFORMIN HCL 417 348 4 8
SIMVASTATIN 343 307 5 6
FUROSEMIDE 341 287 6 4
LEVOTHYROXINE SODIUM 338 311 7 7
ZOLPIDEM TARTRATE 316 229 8 21
LISINOPRIL 291 273 9 5
OMEPRAZOLE 257 221 10 2
METOPROLOL SUCCINATE 252 236 11 14
GLIMEPIRIDE 223 178 12 30
CARISOPRODOL 210 71 R 13 60
LOSARTAN POTASSIUM 203 191 14 34
MELOXICAM 192 163 15 13
LOSARTAN-HYDROCHLOROTHIAZIDE 188 174 16 51
HYDROCHLOROTHIAZIDE 180 137 17 12
NEXIUM 171 128 18 23
PANTOPRAZOLE SODIUM 152 109 19 42
DIOVAN 148 119 20 37
POTASSIUM CHLORIDE 145 133 21 9
ATORVASTATIN CALCIUM 124 121 22 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 124 110 22 16
METOPROLOL TARTRATE 123 110 24 22
ALLOPURINOL 117 91 25 31
GABAPENTIN 116 79 26 10
CARVEDILOL 107 83 27 15
PAROXETINE HCL 106 100 28 65
ATENOLOL 104 93 29 25
ESCITALOPRAM OXALATE 104 82 29 73
DIOVAN HCT 101 81 31 41
TRAMADOL HCL 101 82 31 19
WARFARIN SODIUM 100 85 33 18
SERTRALINE HCL 96 72 34 26
TRIAMTERENE-HCTZ 96 74 34 43
CLOPIDOGREL 93 82 36 28
CYCLOBENZAPRINE HCL 92 74 R 37 50
PLAVIX 82 72 38 40
CEPHALEXIN 81 60 39 84
LANTUS 80 67 40 55
DILTIAZEM ER 74 54 41 118
LYRICA 73 47 42 57
FLUTICASONE PROPIONATE 71 46 43 49
CITALOPRAM HBR 65 58 44 17
AZITHROMYCIN 64 55 45 39
ZETIA 61 61 46 89
RAMIPRIL 60 48 47 86
CRESTOR 58 39 48 29
GLIPIZIDE 56 51 49 81
KLOR-CON 10 56 18 49 95
CLONIDINE HCL 54 40 51 32
AMLODIPINE BESYLATE-BENAZEPRIL 54 42 51 44
ALENDRONATE SODIUM 52 48 53 61
CELEBREX 51 33 54 108
TRICOR 51 31 54 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.